<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Postgraduate Medicine Online via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Postgraduate Medicine Online' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Postgraduate+Medicine+Online&t=Postgraduate+Medicine+Online&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 09:15:16 +0100</lastBuildDate>
        <item>
            <title>Erratum</title>
            <link>http://www.medworm.com/index.php?rid=5672338&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2012.01.2531</link>
            <description>DOI: 10.3810/pgm.2012.01.2531



Morales J. The pharmacologic basis for clinical differences among GLP-1 receptor agonists and DPP-4 inhibitors. Postgrad Med. 2011;123(6):189&amp;ndash;201.







read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672338</comments>
            <pubDate>Fri, 03 Feb 2012 14:21:35 +0100</pubDate>
            <guid isPermaLink="false">5672338</guid>        </item>
        <item>
            <title>Puzzles in Practice</title>
            <link>http://www.medworm.com/index.php?rid=5672335&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2012.01.2530</link>
            <description>Yehia Y. Mishriki, MD, FACP and Brigid Hallinan, DO



DOI: 10.3810/pgm.2012.01.2530











read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672335</comments>
            <pubDate>Fri, 03 Feb 2012 14:21:12 +0100</pubDate>
            <guid isPermaLink="false">5672335</guid>        </item>
        <item>
            <title>Importance of Pharmacokinetic Profile and Timing of Coadministration of Short- and Long-Acting Formulations of Methylphenidate on Patterns of Subjective Responses and Abuse Potential</title>
            <link>http://www.medworm.com/index.php?rid=5672351&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2012.01.2529</link>
            <description>Conclusion: These results emphasize the critical role that formulation type (IR vs OROS) and timing of administration (ascending vs descending phase) play when short- and long-acting formulations are coadministered. Such knowledge provides important information for clinicians about the safety and tolerability of the timing of repeat dosing of various permutations of coadministration of MPH formulations.



Keywords: stimulants; drug abuse liability; attention-deficit/hyperactivity disorder



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672351</comments>
            <pubDate>Fri, 03 Feb 2012 14:18:35 +0100</pubDate>
            <guid isPermaLink="false">5672351</guid>        </item>
        <item>
            <title>The Nature, Assessment, and Treatment of Obsessive-Compulsive Disorder</title>
            <link>http://www.medworm.com/index.php?rid=5672348&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2012.01.2528</link>
            <description>This article provides an introduction to the phenomenology, etiology, and clinical course of OCD. Assessment practices used to evaluate symptom severity are described, and evidence-based treatment options are reviewed, with appropriate distinctions drawn between children and adults. Finally, recommendations for assessment and treatment practices for OCD are explicated.



Keywords: obsessive-compulsive disorder; assessment; treatment; phenomenology; etiology



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672348</comments>
            <pubDate>Fri, 03 Feb 2012 14:18:19 +0100</pubDate>
            <guid isPermaLink="false">5672348</guid>        </item>
        <item>
            <title>Life with Hereditary Angioedema:</title>
            <link>http://www.medworm.com/index.php?rid=5672346&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2012.01.2527</link>
            <description>Then and Now


   Charles Joseph Lane, MD; J. Andrew Grant, MD; and Dane Dougherty, MS



DOI: 10.3810/pgm.2012.01.2527



Abstract: Originally identified in 1882, hereditary angioedema (HAE) is a debilitating and potentially fatal disorder. Although a number of therapies have been identified, many are relatively ineffective or are associated with significant side effect concerns that limit their efficacy. Fortunately, the 2008 approval of plasma-derived C1 esterase inhibitor concentrate for disease prophylaxis provides clinicians with a novel and effective treatment unencumbered with severe side effect concerns for those with this debilitating disorder. However, despite advances in modern medicine, HAE remains a condition marked by a myriad of symptoms that mimic a range of other disorder...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672346</comments>
            <pubDate>Fri, 03 Feb 2012 14:17:05 +0100</pubDate>
            <guid isPermaLink="false">5672346</guid>        </item>
        <item>
            <title>Clinical Management of Elderly Patients with Type 2 Diabetes Mellitus</title>
            <link>http://www.medworm.com/index.php?rid=5672344&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2012.01.2526</link>
            <description>This article reviews the epidemiology, pathophysiology, comorbidities, pharmacokinetic considerations, treatment goals, guidelines, and treatment options for the elderly population, and highlights the current knowledge gaps complicating the management of T2DM in this population.



Keywords: type 2 diabetes mellitus; elderly; metformin; thiazolidinediones; incretin mimetics; DPP-4 inhibitors; GLP-1



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672344</comments>
            <pubDate>Fri, 03 Feb 2012 14:16:41 +0100</pubDate>
            <guid isPermaLink="false">5672344</guid>        </item>
        <item>
            <title>Hypoglycemia, Treatment Discontinuation, and Costs in Patients with Type 2 Diabetes Mellitus on Oral Antidiabetic Drugs</title>
            <link>http://www.medworm.com/index.php?rid=5672342&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2012.01.2525</link>
            <description>Conclusion: Different OAD classes were associated with different levels of risk for hypoglycemic events. Hypoglycemia was associated with a higher risk of antidiabetic treatment discontinuation and significantly increased health care costs.



Keywords: hypoglycemia; type 2 diabetes mellitus; oral antidiabetic drug; treatment discontinuation; health care cost



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672342</comments>
            <pubDate>Fri, 03 Feb 2012 14:15:42 +0100</pubDate>
            <guid isPermaLink="false">5672342</guid>        </item>
        <item>
            <title>The Pharmacokinetic Parameters of a Single Dose of a Novel Nano-formulated, Lower-Dose Oral Diclofenac</title>
            <link>http://www.medworm.com/index.php?rid=5672340&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2012.01.2524</link>
            <description>Conclusion: The novel nano-formulated, lower-dose diclofenac demonstrated lower systemic exposure, comparable Cmax, and faster absorption compared with diclofenac. In light of the advisory issued by worldwide regulatory agencies regarding use of lowest effective doses, these data may permit use of lower NSAID doses that improve safety and tolerability while, at minimum, relieving pain similar to standard formulations.



Keywords: NSAID; diclofenac; nanotechnology



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672340</comments>
            <pubDate>Fri, 03 Feb 2012 14:15:09 +0100</pubDate>
            <guid isPermaLink="false">5672340</guid>        </item>
        <item>
            <title>Contemporary Management of Overactive Bladder</title>
            <link>http://www.medworm.com/index.php?rid=5672337&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2012.01.2523</link>
            <description>This article addresses the contemporary management of overactive bladder, including behavioral and lifestyle modifications, pelvic floor muscle therapy, biofeedback, drug therapy, neuromodulation, and botulinum toxin. We highlight the new drugs and therapies that have been brought into clinical use over the past few years, and discuss important clinical implications of therapy as well as promising new agents that are currently in advanced stages of development.



Keywords: overactive bladder; behavioral modification; biofeedback; antimuscarinics; neuromodulation; botulinum toxin



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672337</comments>
            <pubDate>Fri, 03 Feb 2012 14:14:13 +0100</pubDate>
            <guid isPermaLink="false">5672337</guid>        </item>
        <item>
            <title>Hypoactive Sexual Desire Disorder in Premenopausal Women:</title>
            <link>http://www.medworm.com/index.php?rid=5672334&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2012.01.2522</link>
            <description>This article gives an overview of HSDD in clinical practice and provides 3 case descriptions to illustrate the treatment of low sexual desire in women with diverse histories.



Keywords: primary care provider; metabolic syndrome; breast cancer; androgen insufficiency; female sexual dysfunction; hypoactive sexual desire disorder



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672334</comments>
            <pubDate>Fri, 03 Feb 2012 14:12:49 +0100</pubDate>
            <guid isPermaLink="false">5672334</guid>        </item>
        <item>
            <title>A Systematic Review of Duloxetine for Osteoarthritic Pain:</title>
            <link>http://www.medworm.com/index.php?rid=5672350&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2012.01.2521</link>
            <description>Conclusions: Duloxetine appears efficacious and tolerable for the treatment of chronic pain associated with OA. The NNT and NNH can be used to quantify efficacy and tolerability outcomes and help place duloxetine into clinical perspective. Likelihood to be helped or harmed can illustrate to the clinician and patient the trade-offs between obtaining potential benefits versus harms. Head-to-head comparisons of duloxetine with other interventions for OA, as well as controlled trials of duloxetine in combination with other therapies, would be desirable.



Keywords: adverse events; duloxetine; efficacy; number needed to harm; number needed to treat; osteoarthritis; pain; safety; tolerability



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672350</comments>
            <pubDate>Fri, 03 Feb 2012 14:12:10 +0100</pubDate>
            <guid isPermaLink="false">5672350</guid>        </item>
        <item>
            <title>Evaluation and Pharmacologic Approach to Patients with Resistant Hypertension</title>
            <link>http://www.medworm.com/index.php?rid=5672347&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2012.01.2520</link>
            <description>This article focuses on the safety and efficacy of spironolactone when added to an optimized 3-drug regimen. Additionally, the use of spironolactone in chronic kidney disease and obstructive sleep apnea complicated by resistant hypertension is discussed. These 2 clinical entities are frequently accompanied by resistant hypertension and are indications for the use of spironolactone as well.



Keywords: hypertension; resistant hypertension; spironolactone; treatment; chronic kidney disease; obstructive sleep apnea; renin-angiotensin-aldosterone system



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672347</comments>
            <pubDate>Fri, 03 Feb 2012 14:11:44 +0100</pubDate>
            <guid isPermaLink="false">5672347</guid>        </item>
        <item>
            <title>Recent Advancements in the Treatment of Resistant Hypertension</title>
            <link>http://www.medworm.com/index.php?rid=5672345&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2012.01.2519</link>
            <description>Donald Clark III, MD; Jason L. Guichard, MD, PhD; David A. Calhoun, MD; and Mustafa I. Ahmed, MD



DOI: 10.3810/pgm.2012.01.2519



Abstract: The 2008 scientific statement from the American Heart Association defined resistant hypertension as blood pressure remaining above goal (&amp;lt; 140/90 mm Hg for the general population and &amp;lt; 130/80 mm Hg for patients with diabetes or renal disease) despite the concurrent use of optimal doses of 3 antihypertensive agents of different classes, ideally including a diuretic. Since then, there has been increasing recognition and characterization of patients with resistant hypertension and development of treatment strategies to treat this high-risk population. The role of aldosterone in resistant hypertension has gained increasing recognition. In particul...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672345</comments>
            <pubDate>Fri, 03 Feb 2012 14:09:34 +0100</pubDate>
            <guid isPermaLink="false">5672345</guid>        </item>
        <item>
            <title>Chlorthalidone:</title>
            <link>http://www.medworm.com/index.php?rid=5672343&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2012.01.2518</link>
            <description>This article reviews the comparative clinical data between chlorthalidone and hydrochlorothiazide, the pharmacologic properties that might explain some of their differences regarding half-life and efficacy, and what is known about the effect of chlorthalidone on intermediate endpoints.



Keywords: hypertension; diuretics; chlorthalidone; hydrochlorothiazide



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672343</comments>
            <pubDate>Fri, 03 Feb 2012 14:07:06 +0100</pubDate>
            <guid isPermaLink="false">5672343</guid>        </item>
        <item>
            <title>Current Approaches to the Treatment of Hypertension in Older Persons</title>
            <link>http://www.medworm.com/index.php?rid=5672341&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2012.01.2517</link>
            <description>Wilbert S. Aronow, MD, FACC, FAHA



DOI: 10.3810/pgm.2012.01.2517



Abstract: Hypertension is a major risk factor for cardiovascular disease and is present in 69% of patients with a first myocardial infarction, in 77% of patients with a first stroke, in 74% of patients with chronic heart failure, and in 60% of patients with peripheral arterial disease. Double-blind, randomized, placebo-controlled trials have demonstrated that antihypertensive drug therapy reduces cardiovascular events in patients aged 65 to 79 years. In the Hypertension in the Very Elderly Trial, patients aged &amp;ge; 80 years who were treated with antihypertensive drug therapy had, at 1.8-year follow-up, a 30% reduction in fatal or nonfatal stroke (P = 0.06), a 39% reduction in fatal stroke (P = 0.05), a 21% reduction in a...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672341</comments>
            <pubDate>Fri, 03 Feb 2012 14:06:20 +0100</pubDate>
            <guid isPermaLink="false">5672341</guid>        </item>
        <item>
            <title>Anticoagulation Prophylaxis in Orthopedic Surgery:</title>
            <link>http://www.medworm.com/index.php?rid=5672339&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2012.01.2516</link>
            <description>Conclusion: Traditional cost-effectiveness analysis systematically excludes information related to the safety profiles of these anticoagulants. The efficiency frontier approach presented in this study provides critical information, without substantial effort, to permit a fully informed decision by taking into account all relevant outcomes as they relate to the costs associated with treatment choice.



Keywords: orthopedic surgery; efficiency frontier; venous thromboembolism; total knee arthroplasty; total hip arthroplasty



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672339</comments>
            <pubDate>Fri, 03 Feb 2012 13:58:07 +0100</pubDate>
            <guid isPermaLink="false">5672339</guid>        </item>
        <item>
            <title>Clinical Management Considerations for Dyslipidemia in HIV-Infected Individuals</title>
            <link>http://www.medworm.com/index.php?rid=5672336&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2012.01.2515</link>
            <description>Jeffrey T. Kirchner, DO, FAAFP, AAHIVS



DOI: 10.3810/pgm.2012.01.2515



Abstract: Dyslipidemia is common in patients with human immunodeficiency virus (HIV) and may result in significant morbidity, including coronary heart disease (CHD). Treatment of dyslipidemia in these patients is generally based on the National Cholesterol Education Program Adult Treatment Panel III goals for individuals without HIV. For individuals with &amp;ge; 2 cardiovascular risk factors, the risk of CHD should be evaluated using the Framingham risk calculator and managed accordingly. Switching to an antiretroviral regimen with a favorable lipid profile should be considered before pharmacologic management if virologic suppression can be maintained. Statins are the first-choice therapy for elevated low-density lipop...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672336</comments>
            <pubDate>Fri, 03 Feb 2012 13:57:38 +0100</pubDate>
            <guid isPermaLink="false">5672336</guid>        </item>
        <item>
            <title>Metabolic Syndrome:</title>
            <link>http://www.medworm.com/index.php?rid=5672333&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2012.01.2514</link>
            <description>Definition and Therapeutic Implications


   Hari Prasad, MD; Debra A. Ryan, MD; Ma Florence Celzo, MD; and Dwight Stapleton, MD



DOI: 10.3810/pgm.2012.01.2514



Abstract: The collection of impaired glucose metabolism, central obesity, elevated blood pressure, and dyslipidemia is identified as metabolic syndrome (MetS). It is estimated that approximately 25% of the world&amp;rsquo;s population has MetS. In the United States, MetS is more common in men and Hispanics, and its incidence increases with age. Metabolic syndrome increases the risk of developing cardiovascular disease and type 2 diabetes mellitus. The underlying risk factors include insulin resistance and abdominal obesity. Confusion about MetS exists in part due to the lack of a consensus definition and treatment protocol. Treatme...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672333</comments>
            <pubDate>Fri, 03 Feb 2012 13:56:38 +0100</pubDate>
            <guid isPermaLink="false">5672333</guid>        </item>
        <item>
            <title>Combination Treatment with Atorvastatin Plus Niacin Provides Effective Control of Complex Dyslipidemias:</title>
            <link>http://www.medworm.com/index.php?rid=5672349&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2012.01.2513</link>
            <description>A Literature Review


   James M. McKenney, PharmD



DOI: 10.3810/pgm.2012.01.2513



Abstract: Patients with dyslipidemia receive a cardiovascular benefit from lowering low-density lipoprotein cholesterol (LDL-C). Atorvastatin is currently one of the most effective approved medications for lowering LDL-C, and has been shown to significantly reduce cardiovascular risk in many patient groups. However, even with substantial lowering of LDL-C with atorvastatin, patients still have a residual risk for coronary heart disease. Elevated triglyceride levels and low high-density lipoprotein cholesterol (HDL-C) levels may contribute to this risk. Approved medications targeting these secondary lipid parameters include fibrates, omega-3 fatty acids, and niacin. Among these medications, niacin provide...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672349</comments>
            <pubDate>Fri, 03 Feb 2012 13:54:43 +0100</pubDate>
            <guid isPermaLink="false">5672349</guid>        </item>
        <item>
            <title>Impact of Combination Therapy with Amlodipine and Atorvastatin on Plasma Adiponectin Levels in Hypertensive Patients with Coronary Artery Disease:</title>
            <link>http://www.medworm.com/index.php?rid=5663267&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.11.2496</link>
            <description>Conclusion: The results of this study indicate that along with its antihypertensive and cholesterol-lowering effects, combination therapy with amlodipine and atorvastatin appears to increase plasma adiponectin levels and improve endothelial function.



Keywords: blood pressure; amlodipine; atorvastatin; adiponectin; endothelial function



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663267</comments>
            <pubDate>Tue, 15 Nov 2011 16:20:51 +0100</pubDate>
            <guid isPermaLink="false">5663267</guid>        </item>
        <item>
            <title>Coanalgesics for Chronic Pain Therapy:</title>
            <link>http://www.medworm.com/index.php?rid=5663269&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.11.2504</link>
            <description>A Narrative Review


   Matthew J. Bair, MD, MS and Tamara R. Sanderson, BS



DOI: 10.3810/pgm.2011.11.2504



Abstract: Chronic pain is inadequately treated in many patients, which has led clinicians and researchers to investigate new indications for existing medications with pain-relieving or adjuvant properties. These medications are known as coanalgesics. This review provides an evidence-based overview of select coanalgesics that are used in clinical practice for a variety of neuropathic and musculoskeletal pain disorders. The coanalgesics include antidepressants, anticonvulsants, topical agents, skeletal muscle relaxants, and antispasmodic agents. An update on emergent treatments and uses is also presented. The goals of this article are to highlight coanalgesic treatment options that...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663269</comments>
            <pubDate>Tue, 15 Nov 2011 16:05:37 +0100</pubDate>
            <guid isPermaLink="false">5663269</guid>        </item>
        <item>
            <title>Hypertension and Antihypertensive Therapy in Hispanics and Mexican Americans Living in the United States</title>
            <link>http://www.medworm.com/index.php?rid=5663266&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.11.2494</link>
            <description>This article provides an up-to-date summary of epidemiological and treatment aspects of high blood pressure in the US Hispanic population. Because Mexican Americans constitute approximately 66% of US Hispanics, data sources that focus on Mexican Americans are also discussed.



Keywords: Hispanics; Mexican Americans; hypertension; epidemiology; treatment; cardiovascular diseases



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663266</comments>
            <pubDate>Tue, 15 Nov 2011 16:04:52 +0100</pubDate>
            <guid isPermaLink="false">5663266</guid>        </item>
        <item>
            <title>The Pharmacologic Basis for Clinical Differences Among GLP-1 Receptor Agonists and DPP-4 Inhibitors</title>
            <link>http://www.medworm.com/index.php?rid=5663265&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.11.2508</link>
            <description>Javier Morales, MD



DOI: 10.3810/pgm.2011.11.2508



Abstract: The incretin system plays an important role in glucose homeostasis, largely through the actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Unlike GIP, the actions of GLP-1 are preserved in patients with type 2 diabetes mellitus, which has led to the development of injectable GLP-1 receptor (GLP-1R) agonists and oral dipeptidyl peptidase-4 (DPP-4) inhibitors. GLP-1R agonists&amp;mdash;which can be dosed to pharmacologic levels&amp;mdash;act directly upon the GLP-1R. In contrast, DPP-4 inhibitors work indirectly by inhibiting the enzymatic inactivation of native GLP-1, resulting in a modest increase in endogenous GLP-1 levels. GLP-1R agonists generally lower the fasting and postprandial g...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663265</comments>
            <pubDate>Tue, 15 Nov 2011 16:03:17 +0100</pubDate>
            <guid isPermaLink="false">5663265</guid>        </item>
        <item>
            <title>A 34-Year-Old Man with an Abnormal Right Atrium, Tricuspid Valve, and an Irregular Wide QRS Tachycardia</title>
            <link>http://www.medworm.com/index.php?rid=5663268&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.11.2509</link>
            <description>Nasir Shariff, MD; Ashish Kabra, MD; Martin E. Matsumura, MD; and Yehia Y. Mishriki, MD, FACP



DOI: 10.3810/pgm.2011.11.2509











read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663268</comments>
            <pubDate>Tue, 15 Nov 2011 16:02:42 +0100</pubDate>
            <guid isPermaLink="false">5663268</guid>        </item>
        <item>
            <title>Next-Generation GLP-1 Therapy:</title>
            <link>http://www.medworm.com/index.php?rid=5663283&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2480</link>
            <description>An Introduction to Liraglutide


   Thomas Repas, DO, FACP, FACOI, FACE, CDE



DOI: 10.3810/pgm.2011.09.2480



Abstract: Liraglutide, a once-daily human glucagon-like peptide-1 (GLP-1) analog, was approved by the US Food and Drug Administration in 2010 for the treatment of type 2 diabetes mellitus (T2DM). Glucagon-like peptide-1 enhances insulin secretion and inhibits glucagon in a glucose-dependent manner. The efficacy and safety of liraglutide were evaluated in 6 phase 3 trials in &amp;#x0003E; 4000 patients in the Liraglutide Effect and Action in Diabetes (LEAD) program, in another trial in comparison with sitagliptin, and in another trial where basal insulin was added to liraglutide &amp;#x0002B; metformin. At liraglutide doses of 1.2 mg or 1.8 mg once daily, significant mean reductions in g...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663283</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663283</guid>        </item>
        <item>
            <title>Clinical Implications of Exenatide as a Twice-Daily or Once-Weekly Therapy for Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5663282&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2479</link>
            <description>Vanita R. Aroda, MD and Mary Beth DeYoung, PhD



DOI: 10.3810/pgm.2011.09.2479



Abstract: Exenatide (exendin-4) is a 39-amino acid peptide belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist class that has been demonstrated to improve glycemic control in patients with type 2 diabetes mellitus. Exenatide can be injected twice daily (ExBID) before meals or once weekly (ExQW) when encompassed within dissolvable poly-(D,L-lactide-co-glycolide) microspheres. The primary difference between these formulations is the plasma concentration of exenatide over time, with the long-acting form providing continuous delivery. Clinical trials have examined the similarities and differences in the efficacy and safety/tolerability outcomes of these formulations. In 2 clinical studies spanning ...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663282</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663282</guid>        </item>
        <item>
            <title>Effect of a Behavioral/Nutritional Intervention Program on Weight Loss in Obese Adults:</title>
            <link>http://www.medworm.com/index.php?rid=5663281&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2476</link>
            <description>Conclusions: A behavioral intervention with a low-energy diet including 5 meal replacements and 5 servings of fruits or vegetables enabled obese individuals to lose 13 kg more than control subjects over a 24-week period.



Keywords: obese, adults, low-energy diet, behavioral intervention, nutritional intervention, weight loss 



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663281</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663281</guid>        </item>
        <item>
            <title>Key Concepts of Clinical Trials:</title>
            <link>http://www.medworm.com/index.php?rid=5663280&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2475</link>
            <description>A Narrative Review


   Craig A. Umscheid, MD, MSCE; David J. Margolis, MD, PhD, MSCE; and Craig E. Grossman, MD, PhD



DOI: 10.3810/pgm.2011.09.2475



Abstract: The recent focus of federal funding on comparative effectiveness research underscores the importance of clinical trials in the practice of evidence-based medicine and health care reform. The impact of clinical trials not only extends to the individual patient by establishing a broader selection of effective therapies, but also to society as a whole by enhancing the value of health care provided. However, clinical trials also have the potential to pose unknown risks to their participants, and biased knowledge extracted from flawed clinical trials may lead to the inadvertent harm of patients. Although conducting a well-designed cl...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663280</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663280</guid>        </item>
        <item>
            <title>The Role of the Primary Care Physician in Managing Early Stages of Chronic Kidney Disease</title>
            <link>http://www.medworm.com/index.php?rid=5663279&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2473</link>
            <description>George N. Coritsidis, MD, FACP; Ellena Linden, MD; and Aaron S. Stern, MD



DOI: 10.3810/pgm.2011.09.2473



Abstract: Recent increases in obesity, diabetes, and hypertension, along with the aging of the US population, are driving a dramatic rise in the prevalence of chronic kidney disease (CKD). Despite this increase, the majority of Americans with early-stage CKD remain unaware of their disease. Primary care physicians are at the forefront of efforts for early recognition of CKD and management to control its progression. Patients with CKD should be referred to nephrologists no later than the point at which their estimated glomerular filtration rate reaches 30 mL/min. Nephrology evaluation at this point is essential to facilitate timely preparation for care of end-stage renal disease thr...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663279</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663279</guid>        </item>
        <item>
            <title>Exploring the Impact of Once-Daily OROS® Methylphenidate (MPH) on Symptoms and Quality of Life in Children and Adolescents with ADHD Transitioning From Immediate-Release MPH</title>
            <link>http://www.medworm.com/index.php?rid=5663278&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2457</link>
            <description>Conclusions: In this naturalistic setting, transitioning from IR MPH to OROS&amp;#x000AE; MPH, in patients who showed previously insufficient response and/or poor tolerability, was successful. Patients&amp;#x02019; and parents&amp;#x02019; HRQoL as well as burden of disease showed a clinically relevant improvement. OROS&amp;#x000AE; MPH was generally safe and well tolerated.



Keywords: ADHD , children/adolescents , OROS&amp;#xAE; methylphenidate , transition 



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663278</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663278</guid>        </item>
        <item>
            <title>Response to Roth Letter to the Editor</title>
            <link>http://www.medworm.com/index.php?rid=5663277&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2483</link>
            <description>H. Richard Barthel, MD and Robert A. Axford-Gatley, MD



DOI: 10.3810/pgm.2011.09.2483



Abstract: 







read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663277</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663277</guid>        </item>
        <item>
            <title>Bipolar Disorder is Common in Depressed Primary Care Patients</title>
            <link>http://www.medworm.com/index.php?rid=5663276&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2468</link>
            <description>Conclusions: The high prevalence of patients meeting full criteria for BD and the low rate of identification of BD in primary care patients are consistent with estimates using self-administered questionnaires, but the interview revealed a substantial additional population that could be considered to have subsyndromal BD. Because subsyndromal forms of BD are associated with significant impairment and comorbidity as well as progression to frank BD, recognition of both full and subthreshold BD in primary care practice should be improved.



Keywords: depression, bipolar disorder, primary care, antidepressant, mood stabilizer, diagnosis 



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663276</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663276</guid>        </item>
        <item>
            <title>Management of Chronic Noncancer Pain in Depressed Patients</title>
            <link>http://www.medworm.com/index.php?rid=5663275&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2470</link>
            <description>Robert L. Barkin, MBA, PharmD, FCP; Stacy J. Barkin, MEd, MA, PsyD; Gordon A. Irving, MD, FFA(SA); and Allan Gordon, MD, FRCP(C)



DOI: 10.3810/pgm.2011.09.2470



Abstract: Many patients with chronic noncancer pain present with comorbid depression, which can greatly complicate the treatment of pain. Chronic pain and depression each increase the risk of licit and illicit substance abuse, including the abuse of opioids, and of suicide. Patients attempting suicide may overdose on opioids, which are commonly perceived as potentially harmful, or acetaminophen, an agent that is believed to be safe but is actually the leading cause of liver failure in the United States. Opioids, acetaminophen, and nonsteroidal anti-inflammatory drugs (NSAIDs) have the potential to interact with antidepressants,...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663275</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663275</guid>        </item>
        <item>
            <title>Letter to the Editor:</title>
            <link>http://www.medworm.com/index.php?rid=5663274&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2482</link>
            <description>The Importance of Differentiating Between Topical NSAIDs


   Sanford H. Roth, MD



DOI: 10.3810/pgm.2011.09.2482



Abstract: 







read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663274</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663274</guid>        </item>
        <item>
            <title>Age of Depressed Patient Does Not Affect Clinical Outcome in Collaborative Care Management</title>
            <link>http://www.medworm.com/index.php?rid=5663273&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2467</link>
            <description>Kurt B. Angstman, MS, MD; Kathy L. MacLaughlin, MD; Norman H. Rasmussen, EdD; Ramona S. DeJesus, MD; and David J. Katzelnick, MD



DOI: 10.3810/pgm.2011.09.2467



Abstract: Clinical response and remission for the treatment of depression has been shown to be improved utilizing collaborative care management (CCM). Prior studies have indicated that the presence of mental health comorbidities noted by self-rated screening tools at the intake for CCM are associated with worsening outcomes; few have examined directly the impact of age on clinical response and remission. The hypothesis was that when controlling for other mental health and demographic variables, the age of the patient at implementation of CCM does not significantly impact clinical outcome, and that CCM shows consistent efficacy ...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663273</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663273</guid>        </item>
        <item>
            <title>Review of Current Guidelines on the Care of Postherpetic Neuralgia</title>
            <link>http://www.medworm.com/index.php?rid=5663272&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2469</link>
            <description>Charles E. Argoff, MD



DOI: 10.3810/pgm.2011.09.2469



Abstract: An unfortunate minority of patients with acute herpes zoster (AHZ) experience pain beyond the typical 4-week duration, and roughly 10&amp;#x00025; develop the distressing complication of postherpetic neuralgia (PHN), often defined as pain persisting for &amp;#x0003E; 4 months after the onset of the rash. Elderly patients are at increased risk of PHN. The pathophysiology of PHN is complex, likely involving both peripheral and central processes. This complexity may create opportunities for pharmacologic interventions with multiple differing mechanisms of action. Consequently, complementary combinations of pharmacologic agents are frequently more effective than any monotherapy. Current US and international guidelines on the care of p...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663272</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663272</guid>        </item>
        <item>
            <title>A 27 Year-Old Man with a Midline Lumbar Skin Appendage and Spina Bifida Occulta on Radiograph</title>
            <link>http://www.medworm.com/index.php?rid=5663271&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2481</link>
            <description>Yehia Y. Mishriki, MD, FACP



DOI: 10.3810/pgm.2011.09.2481



Abstract: 







read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663271</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663271</guid>        </item>
        <item>
            <title>Toward Defining Deficient Emotional Self-Regulation in Children with Attention-Deficit/Hyperactivity Disorder Using the Child Behavior Checklist:</title>
            <link>http://www.medworm.com/index.php?rid=5663270&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2459</link>
            <description>Conclusions: The CBCL-DESR profile helped identify a subgroup of children with ADHD who had a psychopathological and functional profile consistent with the clinical concept of DESR.



Keywords: attention-deficit/hyperactivity disorder; affective symptoms; severity of illness index; youth; emotional self-regulation



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663270</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663270</guid>        </item>
        <item>
            <title>Exploring the Impact of Once-Daily OROS® Methylphenidate (MPH) on Symptoms and Quality of Life in Children and Adolescents with ADHD Transitioning From Immediate-Release MPH</title>
            <link>http://www.medworm.com/index.php?rid=5633700&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2457</link>
            <description>Conclusions: In this naturalistic setting, transitioning from IR MPH to OROS&amp;#x000AE; MPH, in patients who showed previously insufficient response and/or poor tolerability, was successful. Patients&amp;#x02019; and parents&amp;#x02019; HRQoL as well as burden of disease showed a clinically relevant improvement. OROS&amp;#x000AE; MPH was generally safe and well tolerated.



Keywords: ADHD , children/adolescents , OROS&amp;#xAE; methylphenidate , transition 



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5633700</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5633700</guid>        </item>
        <item>
            <title>Next-Generation GLP-1 Therapy:</title>
            <link>http://www.medworm.com/index.php?rid=5615457&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2480</link>
            <description>An Introduction to Liraglutide


   Thomas Repas, DO, FACP, FACOI, FACE, CDE



DOI: 10.3810/pgm.2011.09.2480



Abstract: Liraglutide, a once-daily human glucagon-like peptide-1 (GLP-1) analog, was approved by the US Food and Drug Administration in 2010 for the treatment of type 2 diabetes mellitus (T2DM). Glucagon-like peptide-1 enhances insulin secretion and inhibits glucagon in a glucose-dependent manner. The efficacy and safety of liraglutide were evaluated in 6 phase 3 trials in &amp;#x0003E; 4000 patients in the Liraglutide Effect and Action in Diabetes (LEAD) program, in another trial in comparison with sitagliptin, and in another trial where basal insulin was added to liraglutide &amp;#x0002B; metformin. At liraglutide doses of 1.2 mg or 1.8 mg once daily, significant mean reductions in g...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615457</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615457</guid>        </item>
        <item>
            <title>Exploring the Impact of Once-Daily OROS&amp;#x000AE; Methylphenidate (MPH) on Symptoms and Quality of Life in Children and Adolescents with ADHD Transitioning From Immediate-Release MPH</title>
            <link>http://www.medworm.com/index.php?rid=5615456&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2457</link>
            <description>Conclusions: In this naturalistic setting, transitioning from IR MPH to OROS&amp;#x000AE; MPH, in patients who showed previously insufficient response and/or poor tolerability, was successful. Patients&amp;#x02019; and parents&amp;#x02019; HRQoL as well as burden of disease showed a clinically relevant improvement. OROS&amp;#x000AE; MPH was generally safe and well tolerated.



Keywords: ADHD , children/adolescents , OROS&amp;#xAE; methylphenidate , transition 



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615456</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615456</guid>        </item>
        <item>
            <title>Clinical Implications of Exenatide as a Twice-Daily or Once-Weekly Therapy for Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5615455&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2479</link>
            <description>Vanita R. Aroda, MD and Mary Beth DeYoung, PhD



DOI: 10.3810/pgm.2011.09.2479



Abstract: Exenatide (exendin-4) is a 39-amino acid peptide belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist class that has been demonstrated to improve glycemic control in patients with type 2 diabetes mellitus. Exenatide can be injected twice daily (ExBID) before meals or once weekly (ExQW) when encompassed within dissolvable poly-(D,L-lactide-co-glycolide) microspheres. The primary difference between these formulations is the plasma concentration of exenatide over time, with the long-acting form providing continuous delivery. Clinical trials have examined the similarities and differences in the efficacy and safety/tolerability outcomes of these formulations. In 2 clinical studies spanning ...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615455</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615455</guid>        </item>
        <item>
            <title>Effect of a Behavioral/Nutritional Intervention Program on Weight Loss in Obese Adults:</title>
            <link>http://www.medworm.com/index.php?rid=5615454&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2476</link>
            <description>Conclusions: A behavioral intervention with a low-energy diet including 5 meal replacements and 5 servings of fruits or vegetables enabled obese individuals to lose 13 kg more than control subjects over a 24-week period.



Keywords: obese, adults, low-energy diet, behavioral intervention, nutritional intervention, weight loss 



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615454</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615454</guid>        </item>
        <item>
            <title>Key Concepts of Clinical Trials:</title>
            <link>http://www.medworm.com/index.php?rid=5615453&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2475</link>
            <description>A Narrative Review


   Craig A. Umscheid, MD, MSCE; David J. Margolis, MD, PhD, MSCE; and Craig E. Grossman, MD, PhD



DOI: 10.3810/pgm.2011.09.2475



Abstract: The recent focus of federal funding on comparative effectiveness research underscores the importance of clinical trials in the practice of evidence-based medicine and health care reform. The impact of clinical trials not only extends to the individual patient by establishing a broader selection of effective therapies, but also to society as a whole by enhancing the value of health care provided. However, clinical trials also have the potential to pose unknown risks to their participants, and biased knowledge extracted from flawed clinical trials may lead to the inadvertent harm of patients. Although conducting a well-designed cl...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615453</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615453</guid>        </item>
        <item>
            <title>The Role of the Primary Care Physician in Managing Early Stages of Chronic Kidney Disease</title>
            <link>http://www.medworm.com/index.php?rid=5615452&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2473</link>
            <description>George N. Coritsidis, MD, FACP; Ellena Linden, MD; and Aaron S. Stern, MD



DOI: 10.3810/pgm.2011.09.2473



Abstract: Recent increases in obesity, diabetes, and hypertension, along with the aging of the US population, are driving a dramatic rise in the prevalence of chronic kidney disease (CKD). Despite this increase, the majority of Americans with early-stage CKD remain unaware of their disease. Primary care physicians are at the forefront of efforts for early recognition of CKD and management to control its progression. Patients with CKD should be referred to nephrologists no later than the point at which their estimated glomerular filtration rate reaches 30 mL/min. Nephrology evaluation at this point is essential to facilitate timely preparation for care of end-stage renal disease thr...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615452</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615452</guid>        </item>
        <item>
            <title>Response to Roth Letter to the Editor</title>
            <link>http://www.medworm.com/index.php?rid=5615451&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2483</link>
            <description>H. Richard Barthel, MD and Robert A. Axford-Gatley, MD



DOI: 10.3810/pgm.2011.09.2483



Abstract: 







read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615451</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615451</guid>        </item>
        <item>
            <title>Bipolar Disorder is Common in Depressed Primary Care Patients</title>
            <link>http://www.medworm.com/index.php?rid=5615450&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2468</link>
            <description>Conclusions: The high prevalence of patients meeting full criteria for BD and the low rate of identification of BD in primary care patients are consistent with estimates using self-administered questionnaires, but the interview revealed a substantial additional population that could be considered to have subsyndromal BD. Because subsyndromal forms of BD are associated with significant impairment and comorbidity as well as progression to frank BD, recognition of both full and subthreshold BD in primary care practice should be improved.



Keywords: depression, bipolar disorder, primary care, antidepressant, mood stabilizer, diagnosis 



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615450</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615450</guid>        </item>
        <item>
            <title>Management of Chronic Noncancer Pain in Depressed Patients</title>
            <link>http://www.medworm.com/index.php?rid=5615449&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2470</link>
            <description>Robert L. Barkin, MBA, PharmD, FCP; Stacy J. Barkin, MEd, MA, PsyD; Gordon A. Irving, MD, FFA(SA); and Allan Gordon, MD, FRCP(C)



DOI: 10.3810/pgm.2011.09.2470



Abstract: Many patients with chronic noncancer pain present with comorbid depression, which can greatly complicate the treatment of pain. Chronic pain and depression each increase the risk of licit and illicit substance abuse, including the abuse of opioids, and of suicide. Patients attempting suicide may overdose on opioids, which are commonly perceived as potentially harmful, or acetaminophen, an agent that is believed to be safe but is actually the leading cause of liver failure in the United States. Opioids, acetaminophen, and nonsteroidal anti-inflammatory drugs (NSAIDs) have the potential to interact with antidepressants,...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615449</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615449</guid>        </item>
        <item>
            <title>Letter to the Editor:</title>
            <link>http://www.medworm.com/index.php?rid=5615448&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2482</link>
            <description>The Importance of Differentiating Between Topical NSAIDs


   Sanford H. Roth, MD



DOI: 10.3810/pgm.2011.09.2482



Abstract: 







read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615448</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615448</guid>        </item>
        <item>
            <title>Age of Depressed Patient Does Not Affect Clinical Outcome in Collaborative Care Management</title>
            <link>http://www.medworm.com/index.php?rid=5615447&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2467</link>
            <description>Kurt B. Angstman, MS, MD; Kathy L. MacLaughlin, MD; Norman H. Rasmussen, EdD; Ramona S. DeJesus, MD; and David J. Katzelnick, MD



DOI: 10.3810/pgm.2011.09.2467



Abstract: Clinical response and remission for the treatment of depression has been shown to be improved utilizing collaborative care management (CCM). Prior studies have indicated that the presence of mental health comorbidities noted by self-rated screening tools at the intake for CCM are associated with worsening outcomes; few have examined directly the impact of age on clinical response and remission. The hypothesis was that when controlling for other mental health and demographic variables, the age of the patient at implementation of CCM does not significantly impact clinical outcome, and that CCM shows consistent efficacy ...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615447</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615447</guid>        </item>
        <item>
            <title>Review of Current Guidelines on the Care of Postherpetic Neuralgia</title>
            <link>http://www.medworm.com/index.php?rid=5615446&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2469</link>
            <description>Charles E. Argoff, MD



DOI: 10.3810/pgm.2011.09.2469



Abstract: An unfortunate minority of patients with acute herpes zoster (AHZ) experience pain beyond the typical 4-week duration, and roughly 10&amp;#x00025; develop the distressing complication of postherpetic neuralgia (PHN), often defined as pain persisting for &amp;#x0003E; 4 months after the onset of the rash. Elderly patients are at increased risk of PHN. The pathophysiology of PHN is complex, likely involving both peripheral and central processes. This complexity may create opportunities for pharmacologic interventions with multiple differing mechanisms of action. Consequently, complementary combinations of pharmacologic agents are frequently more effective than any monotherapy. Current US and international guidelines on the care of p...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615446</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615446</guid>        </item>
        <item>
            <title>A 27 Year-Old Man with a Midline Lumbar Skin Appendage and Spina Bifida Occulta on Radiograph</title>
            <link>http://www.medworm.com/index.php?rid=5615445&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2481</link>
            <description>Yehia Y. Mishriki, MD, FACP



DOI: 10.3810/pgm.2011.09.2481



Abstract: 







read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615445</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615445</guid>        </item>
        <item>
            <title>Toward Defining Deficient Emotional Self-Regulation in Children with Attention-Deficit/Hyperactivity Disorder Using the Child Behavior Checklist:</title>
            <link>http://www.medworm.com/index.php?rid=5615444&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.09.2459</link>
            <description>Conclusions: The CBCL-DESR profile helped identify a subgroup of children with ADHD who had a psychopathological and functional profile consistent with the clinical concept of DESR.



Keywords: attention-deficit/hyperactivity disorder; affective symptoms; severity of illness index; youth; emotional self-regulation



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615444</comments>
            <pubDate>Thu, 15 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615444</guid>        </item>
        <item>
            <title>Sunscreens for Non-Dermatologists:</title>
            <link>http://www.medworm.com/index.php?rid=5663287&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.07.2315</link>
            <description>What You Should Know When Counseling Patients


   Sarah A. Stechschulte, MD; Robert S. Kirsner, MD, PhD; and Daniel G. Federman, MD



DOI: 10.3810/pgm.2011.07.2315



Abstract:  Ultraviolet (UV) radiation is a notorious environmental carcinogen. Acute and chronic UV radiation exposure increase the risk for skin cancer. Protecting oneself from both UVA and UVB radiation with broad-based sunscreen can prevent certain skin cancers, their precursors, and photoaging. Although sun protection factor only measures UVB protection, it is essential to consider protection from UVA radiation when deciding on a particular sunscreen product. Awareness of particular controversies associated with sunscreen, such as vitamin D deficiency and sunscreen toxicity, is necessary to adequately counsel patients w...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663287</comments>
            <pubDate>Fri, 15 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663287</guid>        </item>
        <item>
            <title>Diabetic Retinopathy in Africa:</title>
            <link>http://www.medworm.com/index.php?rid=5663286&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.07.2311</link>
            <description>Conclusion: As of now, African health care systems are not prepared to deal with the increasing burden of diabetes and its complications. With inappropriate glycemic or blood pressure control, most patients will only seek care once micro- or macrovascular complications have already developed. Given the current difficulty in providing costly therapeutic interventions, a well-planned, cost-effective prevention strategy is required.



Keywords: diabetes ,  diabetic retinopathy ,  Africa 



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663286</comments>
            <pubDate>Fri, 15 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663286</guid>        </item>
        <item>
            <title>Evaluating the OneTouch® Delica™:</title>
            <link>http://www.medworm.com/index.php?rid=5663285&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.07.2308</link>
            <description>In conclusion, OneTouch&amp;#x000AE; Delica&amp;#x02122; was either less painful or no different than the comparator devices when used for fingertip lancing. Innovative lancing devices that cause less pain may improve compliance and persistence with prescribed SMBG.



Keywords: diabetes ,  blood glucose ,  SMBG ,  lancing 



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663285</comments>
            <pubDate>Fri, 15 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663285</guid>        </item>
        <item>
            <title>Iatrogenic Hypoglycemia in Patients with Type 2 Diabetes:</title>
            <link>http://www.medworm.com/index.php?rid=5663284&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.07.2299</link>
            <description>Comparison of Insulin Analog Premixes and Human Insulin Premixes


   Andrew J. Martorella, MD



DOI: 10.3810/pgm.2011.07.2299



Abstract:  Severe iatrogenic&amp;#x02014;or therapy-induced&amp;#x02014;hypoglycemia has been associated with mortality rates as high as 10&amp;#x00025; in patients with type 2 diabetes mellitus (T2DM), and is therefore one of the most significant barriers to glucose management in this patient population. Therapy with modern insulin analogs has been shown to cause significantly less hypoglycemic episodes than human insulins in basal-bolus regimens. This systematic review examines whether a similar benefit has been observed with the insulin analog premixes (aspart 70/30, lispro 75/25, or lispro 50/50) relative to human insulin premix (human 70/30). Consistent with a prior m...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663284</comments>
            <pubDate>Fri, 15 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663284</guid>        </item>
        <item>
            <title>Sunscreens for Non-Dermatologists:</title>
            <link>http://www.medworm.com/index.php?rid=5615461&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.07.2315</link>
            <description>What You Should Know When Counseling Patients


   Sarah A. Stechschulte, MD; Robert S. Kirsner, MD, PhD; and Daniel G. Federman, MD



DOI: 10.3810/pgm.2011.07.2315



Abstract:  Ultraviolet (UV) radiation is a notorious environmental carcinogen. Acute and chronic UV radiation exposure increase the risk for skin cancer. Protecting oneself from both UVA and UVB radiation with broad-based sunscreen can prevent certain skin cancers, their precursors, and photoaging. Although sun protection factor only measures UVB protection, it is essential to consider protection from UVA radiation when deciding on a particular sunscreen product. Awareness of particular controversies associated with sunscreen, such as vitamin D deficiency and sunscreen toxicity, is necessary to adequately counsel patients w...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615461</comments>
            <pubDate>Fri, 15 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615461</guid>        </item>
        <item>
            <title>Diabetic Retinopathy in Africa:</title>
            <link>http://www.medworm.com/index.php?rid=5615460&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.07.2311</link>
            <description>Conclusion: As of now, African health care systems are not prepared to deal with the increasing burden of diabetes and its complications. With inappropriate glycemic or blood pressure control, most patients will only seek care once micro- or macrovascular complications have already developed. Given the current difficulty in providing costly therapeutic interventions, a well-planned, cost-effective prevention strategy is required.



Keywords: diabetes ,  diabetic retinopathy ,  Africa 



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615460</comments>
            <pubDate>Fri, 15 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615460</guid>        </item>
        <item>
            <title>Evaluating the OneTouch® Delica™:</title>
            <link>http://www.medworm.com/index.php?rid=5615459&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.07.2308</link>
            <description>In conclusion, OneTouch&amp;#x000AE; Delica&amp;#x02122; was either less painful or no different than the comparator devices when used for fingertip lancing. Innovative lancing devices that cause less pain may improve compliance and persistence with prescribed SMBG.



Keywords: diabetes ,  blood glucose ,  SMBG ,  lancing 



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615459</comments>
            <pubDate>Fri, 15 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615459</guid>        </item>
        <item>
            <title>Iatrogenic Hypoglycemia in Patients with Type 2 Diabetes:</title>
            <link>http://www.medworm.com/index.php?rid=5615458&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.07.2299</link>
            <description>Comparison of Insulin Analog Premixes and Human Insulin Premixes


   Andrew J. Martorella, MD



DOI: 10.3810/pgm.2011.07.2299



Abstract:  Severe iatrogenic&amp;#x02014;or therapy-induced&amp;#x02014;hypoglycemia has been associated with mortality rates as high as 10&amp;#x00025; in patients with type 2 diabetes mellitus (T2DM), and is therefore one of the most significant barriers to glucose management in this patient population. Therapy with modern insulin analogs has been shown to cause significantly less hypoglycemic episodes than human insulins in basal-bolus regimens. This systematic review examines whether a similar benefit has been observed with the insulin analog premixes (aspart 70/30, lispro 75/25, or lispro 50/50) relative to human insulin premix (human 70/30). Consistent with a prior m...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615458</comments>
            <pubDate>Fri, 15 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615458</guid>        </item>
        <item>
            <title>Diagnosis and Management of Urothelial Carcinoma of the Bladder</title>
            <link>http://www.medworm.com/index.php?rid=5663293&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.05.2283</link>
            <description>Maria F. Tanaka, MD and Guru Sonpavde, MD



DOI: 10.3810/pgm.2011.05.2283



Abstract: Bladder carcinoma is the fourth most common cancer in men and the ninth most common cancer in women in the United States. In 2010, approximately 70 000 new cases of bladder carcinoma (52 000 in men and 18000 in women) and approximately 14000 deaths were expected in the United States. More than 90&amp;#x00025; of bladder carcinomas are classified as urothelial carcinoma (UC), which arise from the urothelium. This epithelium, also known as transitional cell epithelium, lines the urinary tract, which extends from the renal pelvis through the ureters, bladder, and urethra. Urothelial carcinoma of the bladder may present as a non&amp;#x02013;muscle-invasive, muscle-invasive, or metastatic malignancy. In noninvasive ...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663293</comments>
            <pubDate>Sun, 15 May 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663293</guid>        </item>
        <item>
            <title>Developments in Kidney Tumor Nephrometry</title>
            <link>http://www.medworm.com/index.php?rid=5663292&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.05.2282</link>
            <description>Gregory Lieser, MD and Matthew N. Simmons, MD, PhD



DOI: 10.3810/pgm.2011.05.2282



Abstract: With the widespread use of computed tomography imaging, the majority of renal tumors are currently detected incidentally at lower grade and stage. Partial nephrectomy has become the preferred treatment for many of these smaller, lower-stage, organ-confined tumors. Compared with radical nephrectomy, partial nephrectomy is more technically difficult to perform. Specific tumor features such as tumor size, depth, location, and proximity to the kidney vasculature and urinary collecting system affect the difficulty of resection. Classically, feasibility of resection has been determined subjectively. Recently, 3 methodologies have been proposed to provide standard, more objective preoperative assessme...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663292</comments>
            <pubDate>Sun, 15 May 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663292</guid>        </item>
        <item>
            <title>Pharmacological Stress Cardiovascular Magnetic Resonance</title>
            <link>http://www.medworm.com/index.php?rid=5663291&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.05.2295</link>
            <description>Runyawan Chotenimitkhun, MD and W. Gregory Hundley, MD, FACC, FAHA



DOI: 10.3810/pgm.2011.05.2295



Abstract: Over the past decade, cardiovascular magnetic resonance (CMR) has evolved into a cardiac stress testing modality that can be used to diagnose myocardial ischemia using intravenous dobutamine or vasodilator perfusion agents such as adenosine or dipyridamole. Because CMR produces high-resolution tomographic images of the human heart in multiple imaging planes, it has become a highly attractive noninvasive testing modality for those suspected of having myocardial ischemia. The purpose of this article is to review the clinical, diagnostic, and prognostic utility of stress CMR testing for patients with (or suspected of having) coronary artery disease.



Keywords: stress CMR , dobuta...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663291</comments>
            <pubDate>Sun, 15 May 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663291</guid>        </item>
        <item>
            <title>Overview of the Treatment of Acne Vulgaris with Topical Retinoids</title>
            <link>http://www.medworm.com/index.php?rid=5663290&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.05.2294</link>
            <description>Peter Hsu, MS; George I. Litman, MD; and Robert T. Brodell, MD



DOI: 10.3810/pgm.2011.05.2294



Abstract: Acne vulgaris is a common skin disease that is most effectively treated with a combination of topical products and, in some cases, systemic antibiotics. While it is important to treat papules, pustules, nodules, and cysts with topical or systemic antibiotics to suppress bacterial infection, all of these lesions develop from microcomedones. In fact, comedolytic agents enhance the effectiveness of antibiotics and limit the potential for recurrent acne lesions. Because of the superior comedolytic effects of topical retinoids, most patients with acne should be treated with a retinoid unless there is a specific contraindication. Interestingly, only 55&amp;#x00025; of patients with acne who a...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663290</comments>
            <pubDate>Sun, 15 May 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663290</guid>        </item>
        <item>
            <title>Family Practice in Turkey:</title>
            <link>http://www.medworm.com/index.php?rid=5663289&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.05.2292</link>
            <description>This study was undertaken in 2008 in departments of family medicine at universities (n &amp;#x0003D; 21) and training and research hospitals of the Ministry of Health (n &amp;#x0003D; 11). Approximately 250 family practice residents in Turkey were approached. In total, 174 residents participated (70&amp;#x00025; response rate). The survey instruments included a questionnaire with 25 queries and 2 scales: The Postgraduate Hospital Educational Environment Measure and the Maslach Burnout Questionnaire&amp;#x02013;Human Services Survey. The average age of the participants was 32.2 years (standard deviation, 4.5 years; range, 24&amp;#x02013;57 years). The gender distribution was 57.6&amp;#x00025; women and 42.4&amp;#x00025; men. Marital status was 34.7&amp;#x00025; single, 62.9&amp;#x00025; married, and 2.4&amp;#x00025; divorced/wido...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663289</comments>
            <pubDate>Sun, 15 May 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663289</guid>        </item>
        <item>
            <title>Sleep Among Opioid Users</title>
            <link>http://www.medworm.com/index.php?rid=5663288&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.05.2286</link>
            <description>This article summarizes the current literature on the effects of both acute and chronic opioid use on sleep, sleep-disordered breathing, and the current evidence on various treatment options for breathing disorders related to chronic opioid use.



Keywords: opioid analgesics , sleep , sleep-disordered breathing 



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663288</comments>
            <pubDate>Sun, 15 May 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663288</guid>        </item>
        <item>
            <title>Diagnosis and Management of Urothelial Carcinoma of the Bladder</title>
            <link>http://www.medworm.com/index.php?rid=5615466&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.05.2283</link>
            <description>Maria F. Tanaka, MD and Guru Sonpavde, MD



DOI: 10.3810/pgm.2011.05.2283



Abstract: Bladder carcinoma is the fourth most common cancer in men and the ninth most common cancer in women in the United States. In 2010, approximately 70 000 new cases of bladder carcinoma (52 000 in men and 18000 in women) and approximately 14000 deaths were expected in the United States. More than 90&amp;#x00025; of bladder carcinomas are classified as urothelial carcinoma (UC), which arise from the urothelium. This epithelium, also known as transitional cell epithelium, lines the urinary tract, which extends from the renal pelvis through the ureters, bladder, and urethra. Urothelial carcinoma of the bladder may present as a non&amp;#x02013;muscle-invasive, muscle-invasive, or metastatic malignancy. In noninvasive ...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615466</comments>
            <pubDate>Sun, 15 May 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615466</guid>        </item>
        <item>
            <title>Developments in Kidney Tumor Nephrometry</title>
            <link>http://www.medworm.com/index.php?rid=5615465&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.05.2282</link>
            <description>Gregory Lieser, MD and Matthew N. Simmons, MD, PhD



DOI: 10.3810/pgm.2011.05.2282



Abstract: With the widespread use of computed tomography imaging, the majority of renal tumors are currently detected incidentally at lower grade and stage. Partial nephrectomy has become the preferred treatment for many of these smaller, lower-stage, organ-confined tumors. Compared with radical nephrectomy, partial nephrectomy is more technically difficult to perform. Specific tumor features such as tumor size, depth, location, and proximity to the kidney vasculature and urinary collecting system affect the difficulty of resection. Classically, feasibility of resection has been determined subjectively. Recently, 3 methodologies have been proposed to provide standard, more objective preoperative assessme...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615465</comments>
            <pubDate>Sun, 15 May 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615465</guid>        </item>
        <item>
            <title>Pharmacological Stress Cardiovascular Magnetic Resonance</title>
            <link>http://www.medworm.com/index.php?rid=5615464&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.05.2295</link>
            <description>Runyawan Chotenimitkhun, MD and W. Gregory Hundley, MD, FACC, FAHA



DOI: 10.3810/pgm.2011.05.2295



Abstract: Over the past decade, cardiovascular magnetic resonance (CMR) has evolved into a cardiac stress testing modality that can be used to diagnose myocardial ischemia using intravenous dobutamine or vasodilator perfusion agents such as adenosine or dipyridamole. Because CMR produces high-resolution tomographic images of the human heart in multiple imaging planes, it has become a highly attractive noninvasive testing modality for those suspected of having myocardial ischemia. The purpose of this article is to review the clinical, diagnostic, and prognostic utility of stress CMR testing for patients with (or suspected of having) coronary artery disease.



Keywords: stress CMR , dobuta...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615464</comments>
            <pubDate>Sun, 15 May 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615464</guid>        </item>
        <item>
            <title>Overview of the Treatment of Acne Vulgaris with Topical Retinoids</title>
            <link>http://www.medworm.com/index.php?rid=5615463&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.05.2294</link>
            <description>Peter Hsu, MS; George I. Litman, MD; and Robert T. Brodell, MD



DOI: 10.3810/pgm.2011.05.2294



Abstract: Acne vulgaris is a common skin disease that is most effectively treated with a combination of topical products and, in some cases, systemic antibiotics. While it is important to treat papules, pustules, nodules, and cysts with topical or systemic antibiotics to suppress bacterial infection, all of these lesions develop from microcomedones. In fact, comedolytic agents enhance the effectiveness of antibiotics and limit the potential for recurrent acne lesions. Because of the superior comedolytic effects of topical retinoids, most patients with acne should be treated with a retinoid unless there is a specific contraindication. Interestingly, only 55&amp;#x00025; of patients with acne who a...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615463</comments>
            <pubDate>Sun, 15 May 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615463</guid>        </item>
        <item>
            <title>Family Practice in Turkey:</title>
            <link>http://www.medworm.com/index.php?rid=5615462&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.05.2292</link>
            <description>This study was undertaken in 2008 in departments of family medicine at universities (n &amp;#x0003D; 21) and training and research hospitals of the Ministry of Health (n &amp;#x0003D; 11). Approximately 250 family practice residents in Turkey were approached. In total, 174 residents participated (70&amp;#x00025; response rate). The survey instruments included a questionnaire with 25 queries and 2 scales: The Postgraduate Hospital Educational Environment Measure and the Maslach Burnout Questionnaire&amp;#x02013;Human Services Survey. The average age of the participants was 32.2 years (standard deviation, 4.5 years; range, 24&amp;#x02013;57 years). The gender distribution was 57.6&amp;#x00025; women and 42.4&amp;#x00025; men. Marital status was 34.7&amp;#x00025; single, 62.9&amp;#x00025; married, and 2.4&amp;#x00025; divorced/wido...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615462</comments>
            <pubDate>Sun, 15 May 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615462</guid>        </item>
        <item>
            <title>Effect Size of Lisdexamfetamine Dimesylate in Adults with Attention-Deficit/Hyperactivity Disorder</title>
            <link>http://www.medworm.com/index.php?rid=5663295&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.03.2275</link>
            <description>Conclusions:In adults studied in the AWE, medium-to-large model-based effect sizes were maintained from 2 to 14 hours postdose, on a performance-based measure of productivity, suggesting participants experienced improvement in sustained attention throughout the day and into the evening hours. Lisdexamfetamine dimesylate demonstrated a safety profile consistent with long-acting stimulants.



Keywords: lisdexamfetamine dimesylate ,  LDX ,  Vyvanse ,  ADHD ,  amphetamine ,  stimulant 



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663295</comments>
            <pubDate>Tue, 15 Mar 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663295</guid>        </item>
        <item>
            <title>Important Considerations for Treatment with Dietary Supplement Versus Prescription Niacin Products</title>
            <link>http://www.medworm.com/index.php?rid=5663294&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.03.2265</link>
            <description>James M. Backes, PharmD; Robert J. Padley, MD; and Patrick M. Moriarty, MD



DOI: 10.3810/pgm.2011.03.2265



Abstract:  Niacin is a water-soluble B vitamin (B3) known to have favorable effects on multiple lipid parameters, including raising high-density lipoprotein cholesterol (HDL-C) levels and lowering triglycerides (TGs), lipoprotein(a), and low-density lipoprotein cholesterol (LDL-C). Although LDL-C remains the primary target of lipid-altering therapy, current guidelines emphasize HDL-C and other modifiable lipid factors as key secondary targets. Thus, niacin is considered an important therapeutic option to help reduce the risk of cardiovascular disease in patients with mixed dyslipidemia who, in addition to high LDL-C, have elevated TGs and low HDL-C. Although available prescription...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663294</comments>
            <pubDate>Tue, 15 Mar 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5663294</guid>        </item>
        <item>
            <title>Effect Size of Lisdexamfetamine Dimesylate in Adults with Attention-Deficit/Hyperactivity Disorder</title>
            <link>http://www.medworm.com/index.php?rid=5615469&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.03.2275</link>
            <description>Conclusions:In adults studied in the AWE, medium-to-large model-based effect sizes were maintained from 2 to 14 hours postdose, on a performance-based measure of productivity, suggesting participants experienced improvement in sustained attention throughout the day and into the evening hours. Lisdexamfetamine dimesylate demonstrated a safety profile consistent with long-acting stimulants.



Keywords: lisdexamfetamine dimesylate ,  LDX ,  Vyvanse ,  ADHD ,  amphetamine ,  stimulant 



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615469</comments>
            <pubDate>Tue, 15 Mar 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615469</guid>        </item>
        <item>
            <title>Important Considerations for Treatment with Dietary Supplement Versus Prescription Niacin Products</title>
            <link>http://www.medworm.com/index.php?rid=5615468&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.03.2265</link>
            <description>James M. Backes, PharmD; Robert J. Padley, MD; and Patrick M. Moriarty, MD



DOI: 10.3810/pgm.2011.03.2265



Abstract:  Niacin is a water-soluble B vitamin (B3) known to have favorable effects on multiple lipid parameters, including raising high-density lipoprotein cholesterol (HDL-C) levels and lowering triglycerides (TGs), lipoprotein(a), and low-density lipoprotein cholesterol (LDL-C). Although LDL-C remains the primary target of lipid-altering therapy, current guidelines emphasize HDL-C and other modifiable lipid factors as key secondary targets. Thus, niacin is considered an important therapeutic option to help reduce the risk of cardiovascular disease in patients with mixed dyslipidemia who, in addition to high LDL-C, have elevated TGs and low HDL-C. Although available prescription...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615468</comments>
            <pubDate>Tue, 15 Mar 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5615468</guid>        </item>
        <item>
            <title>Practical Guidelines for Evaluating Lead Exposure in Children with Mental Health Conditions:</title>
            <link>http://www.medworm.com/index.php?rid=5663299&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.01.2256</link>
            <description>We present 1) an overview of lead exposure; 2) a detailed summary of current research on the molecular synergy of toxicity caused by lead and stress; 3) a review of human studies that appear to correlate with these molecular findings, including understanding nutrition, environmental enrichment, and caregiving as risk modifiers; and 4) a systematic approach for mental health practitioners in managing children presenting with multiple symptoms and risk factors for mental health conditions. In this article, we review some of the clinical and scientific challenges that relate to the assessment and treatment of children presenting for mental health care who may have potential lead exposure.



Keywords: lead ,  pediatric mental health ,  developmental psychopathology ,  environment 



read mor...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663299</comments>
            <pubDate>Wed, 02 Feb 2011 23:29:54 +0100</pubDate>
            <guid isPermaLink="false">5663299</guid>        </item>
        <item>
            <title>C-Reactive Protein and High-Sensitivity C-Reactive Protein:</title>
            <link>http://www.medworm.com/index.php?rid=5663298&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.01.2252</link>
            <description>This article addresses the causes of CRP elevation and the use of different CRP assays in internal medicine, including cardiology, gastroenterology, rheumatology, infectious diseases, and oncology. We focus on the recent medical literature on the use of hs-CRP in cardiovascular disease risk stratification and management, including updated screening guidelines on the use of hs-CRP, such as those issued in 2009 by the Canadian Cardiovascular Society. We also discuss the Reynolds Risk Score, which incorporates hs-CRP and family history with more standard cardiovascular risk factors (eg, tobacco use, hypertension, and dyslipidemia) and frequently leads to improved recategorization of cardiovascular disease risk levels. As the recently completed Justification for the Use of Statins in Preventio...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663298</comments>
            <pubDate>Wed, 02 Feb 2011 23:28:31 +0100</pubDate>
            <guid isPermaLink="false">5663298</guid>        </item>
        <item>
            <title>A Randomized, Double-Blind, Forced-Titration Study to Compare Olmesartan Medoxomil Versus Losartan Potassium in Patients with Stage 1 and 2 Hypertension</title>
            <link>http://www.medworm.com/index.php?rid=5615470&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fpostgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.01.2248</link>
            <description>Conclusion Treatment with low- and high-dose OM achieved superior SeBP reductions compared with low- and high-dose LOS, resulting in significantly more patients achieving SeBP goal, with similar tolerability.



Keywords: ambulatory BP ,  angiotensin II receptor blocker ,  antihypertensives ,  olmesartan 



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615470</comments>
            <pubDate>Wed, 02 Feb 2011 23:17:35 +0100</pubDate>
            <guid isPermaLink="false">5615470</guid>        </item>
        <item>
            <title>Levels of Acculturation and Effect on Glycemic Control in Mexicans and Mexican Americans with Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5663297&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.01.2246</link>
            <description>Conclusions: Acculturation was not associated with glycemic control in this population. Family physicians should not assume that acculturation difficulties explain poor glycemic control in their Mexican American patients with T2DM.



Keywords: acculturation ,  Mexican ,  Mexican Americans ,  type 2 diabetes mellitus ,  glycemic control ,  hemoglobin A1c 



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663297</comments>
            <pubDate>Wed, 02 Feb 2011 23:09:59 +0100</pubDate>
            <guid isPermaLink="false">5663297</guid>        </item>
        <item>
            <title>The Pharmacological Treatment and Management of Obesity</title>
            <link>http://www.medworm.com/index.php?rid=5663296&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.01.2243</link>
            <description>This article summarizes current lifestyle modifications, pharmacological treatment, and surgical options for the management of obesity and discusses the benefits, limitations, and risks of each. As insights are gained into the pathophysiology of a gut&amp;#x02013;brain neurochemical feedback axis governing satiety and feeding behavior, targets for new pharmacotherapies are being developed. In particular, gut hormone analogs are an attractive antiobesity therapy because they appear to lack the adverse effects historically associated with central nervous system-acting agents.



Keywords: obesity; metabolic syndrome; pharmacological management; comorbidity; diabetes



read more (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663296</comments>
            <pubDate>Wed, 02 Feb 2011 22:48:43 +0100</pubDate>
            <guid isPermaLink="false">5663296</guid>        </item>
        <item>
            <title>Bariatric Surgery in Patients with Type 2 Diabetes:</title>
            <link>http://www.medworm.com/index.php?rid=5663300&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=https%3A%2F%2Fwww.postgradmed.org%2Fdoi%2F10.3810%2Fpgm.2011.01.2242</link>
            <description>A Viable Option


   Randall A. Colucci, MS, MPH, DO



DOI: 10.3810/pgm.2011.01.2242



Abstract: 
The prevalence of obesity is increasing and is co-epidemic with type 2 diabetes mellitus (T2DM). Treatment of obesity has been less than adequate, particularly when managing morbidly obese patients. Research on T2DM has shown a number of new pharmacologic therapies along with the rapid employment of bariatric surgery. Improvement of T2DM, including its remission, after bariatric surgery has been recognized for more than a decade. However, not all procedures are the same. Restrictive procedures, malabsorptive procedures, or a combination of both procedures have their own categorical risks and benefits. Which procedure to choose has to do with many patient selection factors, notwithstanding in...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663300</comments>
            <pubDate>Wed, 02 Feb 2011 22:42:09 +0100</pubDate>
            <guid isPermaLink="false">5663300</guid>        </item>
        <item>
            <title>Carotid Intima-Media Thickness: Knowledge and Application to Everyday Practice</title>
            <link>http://www.medworm.com/index.php?rid=3300939&amp;cid=s_38819_49_f&amp;fid=38820&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fartfull%3Dpgm_01_2010%3Farticle%3D2091</link>
            <description>Heart disease is the primary cause of death in the United States. Fortunately, intervention measures can reduce the risk of cardiovascular disease (CVD) after a patient has been accurately assessed. Atherosclerotic disease, one of the driving forces behind CVD, is not always detected by traditional risk assessment. Carotid intima-media thickness (CIMT), as measured by B-mode ultrasound, is a surrogate marker for atherosclerosis and can be used to detect an accelerated disease process and subclinical disease. Advantages of CIMT are that it is noninvasive, relatively inexpensive, and can be repeatedly performed with no adverse effects on the patient. Carotid intima-media thickness is associated with CVD and is an independent predictor of stroke and myocardial infarction. Therefore, CIMT is v...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3300939</comments>
            <pubDate>Wed, 24 Feb 2010 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">3300939</guid>        </item>
        <item>
            <title>ORIGINAL RESEARCH: Original Research Examines Quality of Sleep among Hypertensive Patients</title>
            <link>http://www.medworm.com/index.php?rid=2687367&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_01_2009%3Farticle%3D1969</link>
            <description>The objective of a study performed by four Nigerian researchers was to examine the quality of &quot;poor sleep&quot; among Nigerian hypertensive patients; specifically, to examine the association between quality of sleep and the severity of hypertension in this population. The researchers hypothesized that severity of hypertension directly influences quality of sleep, and poor quality of sleep may worsen hypertensive conditions. In the study, quality of sleep was measured using the Pittsburgh Sleep Quality Index (PSQI) in chronic hypertensive patients attending a tertiary hospital in Nigeria, and was compared with the PSQI of normal control subjects. The researchers concluded that poor sleep is not only common in hypertensive patients, but may also be associated with a lower health-related quality o...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2687367</comments>
            <pubDate>Mon, 10 Aug 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2687367</guid>        </item>
        <item>
            <title>NEWS BRIEF: Benefits of the Gliptin Class in the Treatment of Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=2687366&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_01_2009%3Farticle%3D1953</link>
            <description>Dipeptidyl peptidase-4 inhibitors (DPP-4s), or gliptins, a relatively new class of drugs for the treatment of type 2 diabetes, work in a unique way to improve insulin secretion from the &amp;#946;-cells of the pancreas in response to an increase in blood sugar and simultaneously decrease glucagon output from the a-cells of the pancreas and decrease hepatic glucose output. This results in a significant improvement in glucose tolerance. Since gliptins improve insulin secretion in response to an increase in blood glucose, it seems appropriate to pair them with drugs that have a different mechanism of action, such as insulin sensitizers or metformin. According to Dr. Nancy Bohannon, improvements in fasting and postprandial glucose levels, improved cell function, and improvement in hemoglobin level...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2687366</comments>
            <pubDate>Mon, 10 Aug 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2687366</guid>        </item>
        <item>
            <title>FEATURE: Practice Pearl Comments on the Importance of HPV and Cervical Cancer Vaccines</title>
            <link>http://www.medworm.com/index.php?rid=2687365&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_11_2008%3Farticle%3D1947</link>
            <description>An article published in the July 2008 issue of Postgraduate Medicine demonstrated the importance of vaccinating patients against human papillomavirus (HPV) in order to prevent the development of cervical cancer. The authors of this study tested the quadrivalent vaccine Gardasil&amp;#174 and the bivalent vaccine Cervarix&amp;#174 to determine their efficacy in preventing infection with high-risk HPV strains in females. As a result of their research, the authors found that the new vaccines were indeed highly effecting in preventing infections and their sequelae; thus, individuals should be vaccinated prior to becoming sexually active. In her commentary on this particular article, Dr. Ellen Miller validates and elucidates the research done, but adds facts pertinent to vaccine usage in different age g...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2687365</comments>
            <pubDate>Mon, 10 Aug 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2687365</guid>        </item>
        <item>
            <title>NEWS BRIEF: Research Provides Insight into Common Chronic Metabolic Complications in HIV-Infected Patients</title>
            <link>http://www.medworm.com/index.php?rid=2687364&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_11_2008%3Farticle%3D1930</link>
            <description>Human immunodeficiency virus (HIV) infection has become a chronic illness that requires continuing medical care and patient self-management education to prevent acute complications and to reduce the risk of long-term complications. Metabolic complications such as dyslipidemia, insulin resistance, diabetes mellitus, obesity, and fat distribution abnormalities are associated with increased risk of cardiovascular disease, which is now a leading cause of death among HIV-infected patients. Furthermore, many antiretroviral drugs are associated with lipid abnormalities. The management of complications such as dyslipidemia includes lifestyle modifications, lipid-lowering therapy, and switching antiretroviral therapy (ART). Findings by Canadian doctors Mazen S. Bader and Deborah V. Kelly point out ...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2687364</comments>
            <pubDate>Mon, 10 Aug 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2687364</guid>        </item>
        <item>
            <title>NEWS BRIEF: Doctor Suggests Improvements for Hyperglycemia Management in Hospitals</title>
            <link>http://www.medworm.com/index.php?rid=2687363&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_11_2008%3Farticle%3D1937</link>
            <description>Although hyperglycemia is often under-recognized and suboptimally managed, it is prevalent in the inpatient setting and is associated with increased morbidity and mortality in patients with and without diabetes. Even slight improvements in hyperglycemia management in hospitalized patients can provide the hospitalist with an opportunity to positively affect morbidity, mortality, and health care costs. However, intensive insulin therapy can increase the risk of hypoglycemia, which often results in the early abandonment of tight glycemic control strategies, or in some cases, no emphasis on glucose control at all. Consequently, the question that Dr. Rattan Juneja presents in this issue of Postgraduate Medicine is whether tight glycemic control strategies should focus on achieving tight glycemi...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2687363</comments>
            <pubDate>Mon, 10 Aug 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2687363</guid>        </item>
        <item>
            <title>FREE: A Clear Relationship Established between HPV and Cervical Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2687362&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Ffree%3Dpgm_11_2008%3Farticle%3D1928</link>
            <description>Despite cervical cancer being considered a preventable disease, it still remains the second most common malignancy in women worldwide, with a higher incidence in underdeveloped countries. Research shows that human papillomavirus (HPV) is considered to be the causative agent of cervical cancer. However, according to Drs. Deepthi Subramanya and Petros Grivas of Hahnemann University Hospital in Philadelphia, HPV infection alone is not sufficient to induce malignant transformation, and other significant cofactors contribute to the multi-step process of tumor formation, such as individual genetic variations as well as environmental factors. Papanicolaou testing (Pap smear) and HPV DNA testing are effective tools used in the screening and diagnosis of cervical neoplastic lesions. In the November...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2687362</comments>
            <pubDate>Mon, 10 Aug 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2687362</guid>        </item>
        <item>
            <title>FEATURE:Research Indicates Prescription Moderation is Necessary in Continuous Opioid Treatment for Chronic Noncancer Pain</title>
            <link>http://www.medworm.com/index.php?rid=2687361&amp;cid=s_38819_49_f&amp;fid=38820&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_07_2009%3Farticle%3D2032</link>
            <description>Physicians treating chronic noncancer pain often face the discrepancy between relieving pain and suffering but also doing no harm. In this manner, many physicians have embraced the concept of long-term opioid treatment for chronic noncancer pain (CNCP), as evidenced by increased prescribing, and many patients have benefitted from these prescriptions. However, prescription opioid abuse has also risen significantly coincident with increased prescribing. Because of the potentially serious adverse effects of opioids, Drs. Stephen Colameco, Joshua Coren, and Carman Ciervo urge physicians to balance potential benefits against risks, especially in individuals at risk for opioid misuse, abuse, or dependence. Their article, published in the July 2009 issue of Postgraduate Medicine, reviews long-ter...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2687361</comments>
            <pubDate>Mon, 10 Aug 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2687361</guid>        </item>
        <item>
            <title>FEATURE: Practice Pearl Considers Use of Glucosamine and Chondroitin Sulfate in the Management of Osteoarthritis</title>
            <link>http://www.medworm.com/index.php?rid=2687360&amp;cid=s_38819_49_f&amp;fid=38820&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_07_2009%3Farticle%3D2030</link>
            <description>Research shows that osteoarthritis affects more than 20 million Americans with an anticipated increase of up to 40 million by the year 2020. The Glucosamine/Chondroitin Sulfate Osteoarthritis Intervention Trial (GAIT), originally published in the New England Journal of Medicine in 2006, evaluated the safety and efficacy of these two drugs and a combination of the two compared to use of a placebo. The authors' findings showed that joint swelling and/or effusion was reduced most significantly by chondroitin sulfate and celecoxib, and the combination of glucosamine and CS was also significant. However, the most statistically significant reduction in osteoarthritis knee pain came from the placebo. Dr. Nicholas DiNubile comments in his Practice Pearl that this study can yield a considerable amo...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2687360</comments>
            <pubDate>Mon, 10 Aug 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2687360</guid>        </item>
        <item>
            <title>NEWS BRIEFS:Cause of Death in Infants of Women with Pregestational Diabetes said to have Close Relationship with Glycemic Control</title>
            <link>http://www.medworm.com/index.php?rid=2687359&amp;cid=s_38819_49_f&amp;fid=38820&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_07_2009%3Farticle%3D2026</link>
            <description>Research has shown that, among infants of mothers with type 1 and type 2 diabetes mellitus, the rate of perinatal mortality tends to be very high. A study published by three doctors in the July 2009 issue of Postgraduate Medicine aims to identify the causes of these stillbirths, compare the rates between type 1 and type 2 diabetes sufferers, and to ascertain the relationship between perinatal mortality and maternal glycemic control. Their research indicated that congenital anomalies were less common in women with type 1 diabetes than those with type 2 diabetes. Furthermore, they conclude that hyperglycemia not only causes fetal macrosomia but also an angiopathy and, consequently, fetal hypoxia. From these results, the doctors are able to relay information to female patients regarding the i...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2687359</comments>
            <pubDate>Mon, 10 Aug 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2687359</guid>        </item>
        <item>
            <title>NEWS BRIEFS: Recognition and Treatment Tips Explained for OSA and Associated Disorders</title>
            <link>http://www.medworm.com/index.php?rid=2687358&amp;cid=s_38819_49_f&amp;fid=38820&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_07_2009%3Farticle%3D2027</link>
            <description>Obstructive sleep apnea (OSA), a common and debilitating condition characterized by upper airway constriction, snoring, disturbed sleep, and excessive sleepiness, can have potentially detrimental consequences if left untreated. As most individuals affected by OSA will initially present in the primary care setting, Dr. Joseph A. Lieberman of Jefferson Medical College suggests that primary care physicians should be able to recognize the condition and thereby refer patients for any necessary treatment. His writings on the subject, featured in the latest issue of Postgraduate Medicine, focus on tips for management, intervention, and treatment of the condition and its resulting effects on the patient's health. Dr. Lieberman concludes that effective intervention for OSA not only provides symptom...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2687358</comments>
            <pubDate>Mon, 10 Aug 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2687358</guid>        </item>
        <item>
            <title>NEWS BRIEFS: Research Conveys Importance of Long-Acting Reversible Contraception</title>
            <link>http://www.medworm.com/index.php?rid=2687357&amp;cid=s_38819_49_f&amp;fid=38820&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_07_2009%3Farticle%3D2025</link>
            <description>Emerging data from clinical studies has evidenced that the use of long-acting reversible contraception (LARC) is the most effective method of contraception with the highest continuation rates and levels of patient satisfaction. Additionally, the appropriate target population for the use of the intrauterine device now includes nulliparous women and adolescents. An article published in the July 2009 issue of Postgraduate Medicine by three doctors from Washington University in St. Louis suggests to such patients that, when initiating a new contraceptive method, one should consider the characteristics of each method, including side effects, effectiveness, and patient acceptability. To be safe, say the researchers, medical comorbidities must be evaluated prior to choosing a method in order to h...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2687357</comments>
            <pubDate>Mon, 10 Aug 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2687357</guid>        </item>
        <item>
            <title>FREE: Doctor Presents Overview of Current Prevention, Screening, and Management Strategies of Osteoporosis</title>
            <link>http://www.medworm.com/index.php?rid=2687356&amp;cid=s_38819_49_f&amp;fid=38820&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Ffree%3Dpgm_07_2009%3Farticle%3D2021</link>
            <description>Numerous medical studies indicate that measures for osteoporosis prevention should begin at childhood and include balanced nutrition, physical activity, and avoidance of risk factors such as smoking. In adulthood, early recognition of osteoporosis followed by timely and effective management can reduce fracture risk; however, the rates of screening and treatment for osteoporosis are surprisingly low. According to Dr. Frank Bonura, the director of Obstetrics and Gynecology at St. Catherine of Siena Medical Center, comprehensive fracture risk assessment should be part of routine patient care. Dr. Bonura explains that several pharmacological therapies are currently available, and clinicians should consider the efficacy and safety profiles of each therapy as well as the individual patient's nee...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2687356</comments>
            <pubDate>Mon, 10 Aug 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2687356</guid>        </item>
        <item>
            <title>NEWS BRIEF: Patients with HIV and Cryptococcosis in America Decreasing While Hospital Admissions Remain Steady</title>
            <link>http://www.medworm.com/index.php?rid=2652654&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_03_2009%3Farticle%3D1983</link>
            <description>A study published in the March issue of Postgraduate Medicine compiled and examined data about HIV-positive patients admitted to the hospital with cryptococcosis, a potentially fatal fungal disease. In the article, doctors reviewed the records of 202 HIV-positive patients who were admitted to both the University of Maryland Medical Center and the Baltimore VA Medical Center for a case of primary cryptococcosis from 1993 to 2004. The study found that although the prevalence of cryptococcosis in the United States is decreasing, the number of HIV-positive patients admitted to these two hospitals did not decline during this period. Many of the patients with this infection also developed meningitis, fungemia (the presence of yeast or fungi in the blood), or pneumonia, leading to further health ...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2652654</comments>
            <pubDate>Wed, 08 Jul 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2652654</guid>        </item>
        <item>
            <title>NEWS BRIEF: A Case Report on Escherichia coli Septic Shock Provides Answers to Heart Attack Mysteries</title>
            <link>http://www.medworm.com/index.php?rid=2652653&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_03_2009%3Farticle%3D1981</link>
            <description>Myocardial dysfunction is a well-known entity in patients presenting with severe sepsis and can be easily recognized by the release of troponin or by echocardiographic findings. Three researchers from Galveston, Texas, present a case of a 59-year-old woman with ST-segment elevations and increased levels of cardiac troponin from Escherichia coli septic shock in the setting of normal coronary angiography in the March issue of Postgraduate Medicine. The case report indicates that elevated cardiac biomarkers in conjunction with electrocardiographic changes are valuable in diagnosing acute coronary syndrome (ACS). Furthermore, high troponin levels in patients with sepsis result from various mechanisms, including hypoperfusion or direct extension of infection to cardiac tissue, and can also serv...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2652653</comments>
            <pubDate>Wed, 08 Jul 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2652653</guid>        </item>
        <item>
            <title>NEWS BRIEF: Major Trials in Cardiovascular Disease Evaluate New Agents in the Treatment of MI</title>
            <link>http://www.medworm.com/index.php?rid=2652652&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_03_2009%3Farticle%3D1973</link>
            <description>An article published by three doctors from the Ochsner Medical Center in New Orleans provides information and commentary on recent clinical trials related to primary prevention in cardiovascular diseases including lipids, hypertension, and diabetes. It also focuses on novel therapeutic advances in heart failure with devices and therapeutic agents. In addition, the researchers explore trials looking at the effects of the investigational agents azimilide and dronedarone in the treatment of arrhythmias, application of established therapies and devices to larger populations, and the impact of hypercoagulability and aortic arch plaques on the incidence of stroke. The doctors compared the use of percutaneous coronary intervention with coronary artery bypass grafting surgery in patients with diab...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2652652</comments>
            <pubDate>Wed, 08 Jul 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2652652</guid>        </item>
        <item>
            <title>FEATURE: Abuse and Overdose of OxyContin® Discussed in March Issue of Postgraduate Medicine</title>
            <link>http://www.medworm.com/index.php?rid=2652651&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_03_2009%3Farticle%3D1988</link>
            <description>The propensity for addiction to the pain medication OxyContin&amp;#174; and the recent trend of increased prescription drug abuse have made it imperative for physicians and health care providers to recognize the clinical presentation of overdose and know how to manage associated complications. In this review of OxyContin&amp;#174;, published in the March issue of Postgraduate Medicine, four researchers from New Jersey discuss current trends in its abuse and the clinical presentation of overdose, as well as the specific effects of the drug on body systems and the recognition of symptomatology, differential diagnosis, and management. OxyContin&amp;#174; overdose presents with a typical opiate toxidrome, including decreased respirations, miosis, hypothermia, bradycardia, hypotension, and altered mental s...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2652651</comments>
            <pubDate>Wed, 08 Jul 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2652651</guid>        </item>
        <item>
            <title>FEATURE: Gender Differences in Heart Disease Revealed in a New Study Published in Postgraduate Medicine</title>
            <link>http://www.medworm.com/index.php?rid=2652650&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_03_2009%3Farticle%3D1977</link>
            <description>In a new study published in the March issue of Postgraduate Medicine, doctors from the Department of Cardiology at the University of North Texas Medical Center investigated the different ways that cardiovascular disease, specifically coronary artery disease (CAD), presents itself in men and women. The article discusses the atypical symptoms that women with CAD exhibit, a fact that often leads doctors to underdiagnose the disease. By illuminating these sex-based distinctions, these doctors hope to help others realize the importance of critical investigation in women demonstrating these differing symptoms. The study reveals that women who are diagnosed with CAD typically receive fewer medications for treatment on admission to the hospital and after being discharged, and they are also less li...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2652650</comments>
            <pubDate>Wed, 08 Jul 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2652650</guid>        </item>
        <item>
            <title>FREE: Improving Microvascular Outcomes in Patients with Diabetes through Management of Hypertension</title>
            <link>http://www.medworm.com/index.php?rid=2652649&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Ffree%3Dpgm_03_2009%3Farticle%3D1980</link>
            <description>It is well known that diabetes mellitus is an independent risk factor for cardiovascular disease. In a patient with diabetes, hypertension and hyperglycemia compound and greatly increase the risk of microvascular complications. Thus, early recognition and aggressive treatment of both hyperglycemia and hypertension may prevent vision loss and chronic kidney disease, the devastating outcomes of these microvascular complications. A PubMed search was conducted by Dr. Janet B. McGill of Washington University School of Medicine to identify randomized controlled trials that evaluated hypertension control and microvascular outcomes in patients with diabetes. Several clinical trials yielded promising data with renin-angiotensin-aldosterone system (RAAS) inhibitors, and attainment of BP control with...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2652649</comments>
            <pubDate>Wed, 08 Jul 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2652649</guid>        </item>
        <item>
            <title>FREE: Original Research: Study Reveals Results of Telmisartan Plus Amlodipine in Patients with Moderate or Severe Hypertension</title>
            <link>http://www.medworm.com/index.php?rid=2652648&amp;cid=s_38819_49_f&amp;fid=38819&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Ffree%3Dpgm_03_2009%3Farticle%3D1972</link>
            <description>Recent findings show that even the most advanced improvements in blood pressure control in the United States today are inadequate in relation to the prevalence of hypertension today. Patients with moderate-to-severe hypertension frequently require 2 or more antihypertensives to achieve blood pressure control. An angiotensin receptor blocker (ARB) plus a calcium channel blocker (CCB) combination seems particularly attractive for these difficult-to-control patients. A study published in the March issue of Postgraduate Medicine found that blood pressure reductions were significantly greater with combination therapies than respective monotherapies. More specifically, the combination of telmisartan plus amlodipine provides effective blood pressure reduction at all clinically relevant doses, all...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2652648</comments>
            <pubDate>Wed, 08 Jul 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2652648</guid>        </item>
        <item>
            <title>NEWS BRIEF: OTC Extended-Release Formulation Said to be Effective and Safe</title>
            <link>http://www.medworm.com/index.php?rid=2652647&amp;cid=s_38819_49_f&amp;fid=38820&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_05_2009%3Farticle%3D2018</link>
            <description>It is well documented that acute bacterial respiratory infections require treatment with antibiotics, which can often be purchased over-the-counter. The original study on extended-release oral guaifenesin/pseudoephedrine aimed to assess its safety and efficacy during treatment of ten respiratory symptoms for patients in the study presenting with acute respiratory infection (ARI). The researchers concluded, and Dr. George Kikano agrees, that the drug treatment shortened the time to relief and improved respiratory symptoms better than placebo. However, says Kikano, the use of antibiotics alone may not be a sufficient approach for symptom relief, and the use of simultaneous adjunctive therapies can further alleviate symptoms such as excessive mucus, respiratory congestion, and cough.
The ful...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2652647</comments>
            <pubDate>Wed, 08 Jul 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2652647</guid>        </item>
        <item>
            <title>NEWS BRIEF: Puzzles in Practice</title>
            <link>http://www.medworm.com/index.php?rid=2652646&amp;cid=s_38819_49_f&amp;fid=38820&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_05_2009%3Farticle%3D2017</link>
            <description>Puzzles in Practice Encourages Doctors to Form Diagnoses Based on Case Reports
A 63-year-old white man is seen for a routine examination. His medical history is significant for type 2 diabetes mellitus of 16 years duration, diabetic peripheral sensory neuropathy, hypertension, and hyperlipidemia. He smoked 1 pack of cigarettes daily for 20 years but quit many years ago. Salient findings on physical examination include decreased light touch and vibratory sense in the feet, decreased pedal pulses, and hyperpigmented patches on the lower legs. The patches have normal sensation and a hint of atrophy. There is no overlying scale. What is your diagnosis?
This case report is presented to readers of Postgraduate Medicine, particularly primary care physicians, in order to determine a diagnosis ba...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2652646</comments>
            <pubDate>Wed, 08 Jul 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2652646</guid>        </item>
        <item>
            <title>NEWS BRIEF: Impact of an ICU Telemedicine Program on a Rural Health Care System</title>
            <link>http://www.medworm.com/index.php?rid=2652645&amp;cid=s_38819_49_f&amp;fid=38820&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_05_2009%3Farticle%3D2016</link>
            <description>In a study published in the May issue of Postgraduate Medicine, six researchers from South Dakota, Texas, and New York evaluated the impact of a 15-hospital, rural, multi-state intensive care unit (ICU) telemedicine program. Acute Physiology, Age, and Chronic Health Evaluation (APACHE&amp;#174; III) scores, raw mortality rates, and actual-to-predicted length of stay (LOS) ratios and mortality ratios were used in research. Their surveys evaluated program impact in smaller facilities and satisfaction of the physicians staffing the remote center. Smaller facilities' staff reported improvements in the quality of critical care services and reduced transfers. In regional hospitals, acuity scores increased (retention of sicker patients) while raw mortality was the same or lower. Length of stay ratios...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2652645</comments>
            <pubDate>Wed, 08 Jul 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2652645</guid>        </item>
        <item>
            <title>FREE: Therapeutic Lifestyle Strategies and Hypertension Management Developed for African Americans</title>
            <link>http://www.medworm.com/index.php?rid=2652644&amp;cid=s_38819_49_f&amp;fid=38820&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Ffree%3Dpgm_05_2009%3Farticle%3D2015</link>
            <description>African Americans with high blood pressure (BP) can benefit greatly from therapeutic lifestyle changes (TLC) such as diet modification, physical activity, and weight management; however, they and their health care providers face many barriers in modifying health behaviors. A multidisciplinary panel consisting of thirteen American researchers synthesized the scientific data on TLC in African Americans for efficacy in improving BP control, barriers to behavioral change, and strategies to overcome those barriers. They assert that therapeutic lifestyle change interventions should emphasize patient self-management, supported by providers, family, and the community, and should be tailored to an individual's cultural heritage, beliefs, and behavioral norms. The panel cited limited progress with i...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2652644</comments>
            <pubDate>Wed, 08 Jul 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2652644</guid>        </item>
        <item>
            <title>FEATURED: Chronic Kidney Disease and the Proper Management of Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=2652643&amp;cid=s_38819_49_f&amp;fid=38820&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_05_2009%3Farticle%3D2002</link>
            <description>This article, co-written by doctors Ziauddin Ahmed, Barbara Simon, and Devasmita Choudhury, discusses proper screening, identification, and management in the different stages of DKD, including special considerations for dialysis and transplant patients. The authors also review information on altered metabolism of medications and the appropriate use of diabetic agents, including recommendations for management of glucose control in CKD.
The full article can be accessed on Postgraduate Medicine's website at www.postgradmed.com. (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2652643</comments>
            <pubDate>Wed, 08 Jul 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2652643</guid>        </item>
        <item>
            <title>FEATURED: New SUNY Buffalo Study Examines Hypogonadotropic Hypogonadism in Men with Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=2652642&amp;cid=s_38819_49_f&amp;fid=38820&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Fart%3Dpgm_05_2009%3Farticle%3D2001</link>
            <description>This article, written by four authors from SUNY Buffalo's Division of Endocrinology, Diabetes, and Metabolism, discusses the pathophysiology, signs, and symptoms of hypogonadotropic hypogonadism. The authors report that clinical trials are required to determine whether testosterone replacement therapy alleviates insulin resistance, inflammation, and symptoms related to sexual dysfunction care.
The full article can be accessed on Postgraduate Medicine's website at www.postgradmed.com. (Source: Postgraduate Medicine Online)</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2652642</comments>
            <pubDate>Wed, 08 Jul 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2652642</guid>        </item>
        <item>
            <title>PRESS RELEASE: Efficacy of Liraglutide in Treatment of Type 2 Diabetes</title>
            <link>http://www.medworm.com/index.php?rid=2652641&amp;cid=s_38819_49_f&amp;fid=38820&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Ffree%3Dpgm_05_2009%3Farticle%3D1998</link>
            <description>Over 180 million people worldwide suffer from diabetes mellitus and experts expect that number to double within the next 20 years. Even though many acknowledge the growing danger of diabetes, few medications effectively target the underlying cause of the disorder's progression, the deterioration of beta-cell function. Scientists searching for more effective treatments of diabetes published their most recent findings in the May issue of Postgraduate Medicine in an article named &quot;Insights from the Liraglutide Clinical Development Program- the Liraglutide Effect and Action in Diabetes (LEAD) Studies.&quot; By using a study group of 4400 patients suffering from diabetes, the scientist were able to prove that liraglutide, either by itself or combined with other diabetes medications, is able to impro...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2652641</comments>
            <pubDate>Wed, 08 Jul 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2652641</guid>        </item>
        <item>
            <title>PRESS RELEASE: Study Shows Adding Liraglutide to Oral Antidiabetic Drugs Has Extra Benefits</title>
            <link>http://www.medworm.com/index.php?rid=2652640&amp;cid=s_38819_49_f&amp;fid=38820&amp;url=http%3A%2F%2Fwww.postgradmed.com%2Findex.php%3Ffree%3Dpgm_05_2009%3Farticle%3D1997</link>
            <description>In a new study published in the May issue of Postgraduate Medicine entitled &quot;Adding Liraglutide to Oral Antidiabetic Drug Monotherapy: Efficacy and Weight Benefits&quot;, scientists in Europe conducted a study to see the effect of liraglutide, a substance used for glycemic control, when used in tandem with other oral antidiabetic drugs (OADs). On their own, these drugs, which are prescribed after someone has initially been diagnosed with type 2 diabetes, often have adverse side effects, including unwanted weight gain and a higher occurrence of hypoglycemic episodes. On the other hand, liraglutide has a history of helping diabetes patients achieve weight loss and a greater level of glycemic control.
After studying the effect of the combination therapy on 386 patients, the scientists concluded t...</description>
            <author>Postgraduate Medicine Online</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2652640</comments>
            <pubDate>Wed, 08 Jul 2009 08:47:00 +0100</pubDate>
            <guid isPermaLink="false">2652640</guid>        </item>
    </channel>
</rss>

